The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-world survival of patients (pts) with colorectal adenocarcinoma liver metastases (CRLM) treated with transarterial radioembolization (TARE).
 
Sharmeen Mahmood
No Relationships to Disclose
 
Garo Greg Hagopian
No Relationships to Disclose
 
Ben Sadeghi
No Relationships to Disclose
 
Jeffrey V Kuo
No Relationships to Disclose
 
David Imagawa
Consulting or Advisory Role - Incyte
 
Dayantha Fernando
No Relationships to Disclose
 
Nadine Abi-Jaoudeh
Stock and Other Ownership Interests - Bruin Biosciences
Consulting or Advisory Role - AstraZeneca; Eisai; Genentech/Roche; Histosonics; innova vascular; Johnson & Johnson/CERENOVUS; Lynx Group; Medtronic; Pfizer; QED Therapeutics
Research Funding - AngioDynamics (Inst); BlackSwan Vascular (Inst); Guerbet (Inst); Instylla (Inst); Philips Healthcare (Inst); Sillajen (Inst); Sirtex Medical (Inst); Teclison (Inst)
 
Farshid Dayyani
Employment - Roche (I)
Consulting or Advisory Role - Array BioPharma; Eisai; Exelixis; Genentech/Roche; QED Therapeutics; Signatera
Speakers' Bureau - Amgen; Deciphera; Eisai; Exelixis; Genentech/Roche; ipsen; Natera; SERVIER; Sirtex Medical
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Exelixis (Inst); Genentech (Inst); Ipsen (Inst); Merck (Inst); Taiho Pharmaceutical (Inst)